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Abstract
Background—Perinatal depression (PND) is a common complication of pregnancy and
postpartum associated with significant morbidity.
Objectives—We had three goals: 1) to explore the performance of a new lifetime version of the
Edinburgh Postnatal Depression Scale (EPDS-Lifetime) to assess lifetime prevalence of PND; 2)
to assess prevalence of lifetime PND in women with prior histories of MDD; and 3) to evaluate
risk factors for PND.
Methods—Subjects were from the Netherlands Study of Depression and Anxiety (NESDA). The
EPDS was modified by adding lifetime PND screening questions, assessing worst episode and
symptom timing of onset.
Results—Of 682 women with lifetime MDD and a live birth, 276 (40.4%) had a positive EPDS
score of ≥12 consistent with PND. Women with PND more often sought professional help (p
<0.001), and received treatment (p =0.001). Independent risk indicators for PND included younger
age, higher education, high neuroticism, childhood trauma, and sexual abuse.
Conclusions—We found that two in five parous women with a history of MDD had lifetime
PND and that the PND episodes were more severe than MDD occurring outside of the perinatal
period. The EPDS-Lifetime shows promise as a tool for assessing lifetime histories of PND in
clinical and research settings.
INTRODUCTION
Perinatal depression (PND) is a common complication of pregnancy and the postpartum
period and is often defined as a major depressive episode (MDD) occurring either during
pregnancy or postpartum (O'Hara and Swain 1996; Yonkers, Ramin et al. 2001) (Gavin,
Gaynes et al. 2005; Gaynes, Gavin et al. 2005). The time of onset in the postpartum period is
a matter of some debate in the field (Elliott 2000; Wisner, Moses-Kolko et al. 2010). The
DSM defines postpartum depression (PPD) as onset of symptoms occurring within the first
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four weeks postpartum(DSM-IV 1994). However, in clinical practice, a broader definition is
frequently described, such as onset of symptoms in the first 3–6 months postpartum, and
thus, could be considered a reasonable definition both clinically and
epidemiologically(Wisner, Moses-Kolko et al. 2010). The prevalence of PND ranges from
10–15% and has been associated with poor childbirth outcomes such as preterm birth
(Rahman, Iqbal et al. 2004; Smith, Shao et al. 2010). Other significant consequences include
maternal suicide and infanticide (Murray and Stein 1989) (Flynn, Davis et al. 2004;
Marmorstein, Malone et al. 2004; Lindahl, Pearson et al. 2005; Feldman, Granat et al. 2009;
Field 2010), decreased maternal sensitivity and engagement,(Network 1999; Campbell,
Brownell et al. 2004) and decreased attachment with the infant (Network 1999; Campbell,
Brownell et al. 2004; Paulson, Dauber et al. 2006) (Fleming and Corter 1988; Murray and
Cooper 1997; O'Connor and Zeanah 2003; Bergman, Sarkar et al. 2010).
Given the prevalence and adverse consequences of PND, lifetime PND assessment should
be an essential component of the medical history of all reproductive aged women. A lifetime
history of PND significantly increases the risk for a subsequent episode (O'Hara and Swain
1996; Robertson, Grace et al. 2004; Milgrom, Gemmill et al. 2008; Micali, Simonoff et al.
2011; Viguera, Tondo et al. 2011). The risk of recurrence of PPD after a previous episode is
25% (Wisner, Parry et al. 2002) and women with a history of PND must be carefully
followed as they have increased risk for both unipolar and bipolar depression (Kumar and
Robson 1984) (Munk-Olsen, Laursen et al. 2011). Unfortunately, assessment of lifetime
PND is generally not obtained in primary care, obstetrical, or mental health settings,
although assessment of current PND is increasingly common. Other than asking a few
general screening questions that do not allow for accurate classification, PND is not
specifically assessed by most structured psychiatric diagnostic instruments including the
Structured Clinical Interview for DSM-IV (First MB 1995), the Composite International
Diagnostic Interview, (Hans-Ulrich; Wittchen, Burke et al. 1989; Wittchen, Robins et al.
1991) and the Diagnostic Interview for Genetic Studies (Nurnberger, Blehar et al. 1994).
Our goal was to develop a lifetime assessment instrument for PND that could be used in
both clinical and research settings. Cox et al. previously reported that women demonstrate
accurate recall of prior episodes of PPD including both severity and duration of symptoms.
(Cox JL 1984) Therefore, we focused on modifying the Edinburgh Postnatal Depression
Scale (EPDS) to assess lifetime episodes of PND (Cox, Holden et al. 1987). The EPDS is a
common and widely studied PND screening instrument (Cox, Holden et al. 1987; Cox,
Murray et al. 1993; Boyd, Le et al. 2005; Hewitt and Gilbody 2009). The 10-item, self-
reported EPDS focuses on current symptoms, has been successfully used during both
pregnancy and postpartum (Cox, Holden et al. 1987; Gaynes, Gavin et al. 2005; Flynn,
Sexton et al. 2011), and minimizes confounding of somatic symptoms of MDD with the
demands inherent to parenting an infant (e.g., insomnia) (Cox, Holden et al. 1987).
In addition to assessing lifetime history of PND, we wanted to assess its risk factors. The
literature documents a wide range of risk factors for PND (Warner, Appleby et al. 1996;
O'Hara 2009) (O'Hara and Swain 1996; Robertson, Grace et al. 2004; Milgrom, Gemmill et
al. 2008), including those with overlap with non-perinatal MDD (i.e., MDD outside of the
perinatal period), such as maternal age (Rubertsson, Waldenström et al. 2003), education
(Tammentie, Tarkka et al. 2002), family history, prior history of MDD (Beck 2001;
Milgrom, Gemmill et al. 2008; Kupfer, Frank et al. 2011), (O'Hara and Swain 1996), social
support (Brugha, Sharp et al. 1998; Milgrom, Gemmill et al. 2008), anxiety disorders
(Beesdo, Bittner et al. 2007; Moffitt, Harrington et al. 2007; Penninx, Nolen et al. 2011),
and histories of abuse/trauma (Meltzer-Brody, Zerwas et al. ; Kendall-Tackett 2007;
Records and Rice 2009; Silverman and Loudon 2010). However, one of the major gaps in
prior studies is the lack of a comparison group of women with a diagnosis of lifetime non-
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perinatal MDD. Previous studies usually recruited perinatal women from the general
population and then inquired about a prior history of MDD (O'Hara and Swain 1996;
Milgrom, Gemmill et al. 2008). Some prior studies of perinatal risk factors lack any
assessment of past psychiatric history (Warner, Appleby et al. 1996; Tammentie, Tarkka et
al. 2002; Rubertsson, Waldenström et al. 2003). In order to address these gaps, we wanted to
measure the prevalence and risk factors of PND in a cohort of women with documented
histories of lifetime MDD.
The three goals of our study were: 1) to explore the performance of a new lifetime version of
the Edinburgh Postnatal Depression Scale (EPDS-Lifetime) to assess lifetime prevalence of
PND; 2) to assess prevalence of lifetime PND in women with histories of MDD; and 3) to
evaluate risk factors for PND, including age, education, family history, personality, and




NESDA is an ongoing, multi-site naturalistic cohort study examining the long-term course
and consequences of MDD and anxiety disorders in adults. A detailed description of the
NESDA study design and sampling procedures can be found elsewhere (Penninx, Nolen et
al. ; Penninx, Beekman et al. 2008). Briefly, 2,981 subjects were included for the baseline
assessment in 2004–2007, consisting of healthy controls (22%) and subjects with
depressive/anxiety disorders (78%) (Penninx, Beekman et al. 2008). To represent various
settings and stages of psychopathology, subjects were recruited from the community (19%),
primary care (54%) and outpatient mental health care services (27%). Community-based
participants had previously been identified in a population-based study; primary care
participants were identified through a three-stage screening procedure (involving the
Kessler-10 (Kessler, Andrews et al. 2002) and the short-form Composite International
Diagnostic Interview psychiatric interview by phone) (Gigantesco and Morosini 2008)
conducted among a random sample primary care; and mental healthcare participants were
recruited consecutively when newly enrolled at one of the 17 participating mental health
organization locations (Bijl, van Zessen et al. 1998) (Landman-Peeters, Hartman et al.
2005).(Donker, Comijs et al.). Controls were recruited from two groups; 1) from primary
care settings where subjects had agreed to undergo a mental health screen and were
completely negative for a psychiatric disorder; and 2) a prior cohort study conducted in The
Netherlands that recruited adolescents at risk for anxiety and depression based on family
history(Landman-Peeters, Hartman et al. 2005)._ All subjects were administered the
Composite International Diagnostic Interview (version 2.1) (Wittchen, Robins et al. 1991) to
establish DSM-IV diagnoses of psychiatric disorders (DSM-IV 1994), including MDD. The
CIDI is highly reliable and valid in assessing psychiatric disorders(Wittchen, Robins et al.
1991) and was administered by specially trained research staff. Subjects with insufficient
command of the Dutch language or a primary clinical diagnosis of bipolar disorder,
obsessive compulsive disorder, severe substance use disorder, psychotic disorder or organic
psychiatric disorder were excluded.
For the present study, we used data from the baseline, 2-year and 4-year follow-up
assessments with the EPDS-Lifetime included in the 4-year assessment. The research
protocol was approved by the Ethics Committees of participating universities, and all
participants provided written informed consent.
Figure 1 depicts a flowchart illustrating NESDA. Of the 2981 subjects enrolled into NESDA
at baseline, 2402 subjects had complete data at the 4-year follow-up assessment. Subject
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inclusion criteria were as follows: presence of a lifetime MDD (excluded: N=743), women
(excluded: N=511) and a history of one or more live births (excluded: N=466), leaving a
sample of 682 female subjects for analyses. We included only those women who had
delivered a living child to avoid confounding related to pregnancy loss and grief reactions.
We also included a control group of women (N=141) who gave birth to a living child but did
not have lifetime MDD or anxiety (based on the CIDI) and did not have a diagnosis of PND
(based on the modified EPDS).
PND assessment
We are unaware of a gold-standard assessment tool for lifetime assessment of PND (Gaynes,
Gavin et al. 2005). We therefore developed a new lifetime PND questionnaire derived from
the EPDS (Table 1) (Cox, Holden et al. 1987). The EPDS was designed to identify current
PND symptoms and has good sensitivity and specificity (Gavin, Gaynes et al. 2005). We
modifed the EPDS to assess lifetime PND retrospectively (EPDS-Lifetime). A positive score
on the original 10-item EPDS was defined as a total score ≥12 and based on standard
literature cut-off scores (Cox, Holden et al. 1987; Wisner, Parry et al. 2002). We expanded
the EPDS-Lifetime by adding two screening questions prior to the 10-item EPDS: 1)
“During how many of your pregnancies did you feel sad, miserable, or very anxious? By this
we mean a period of at least 2 weeks when you were not yourself and which was worse than
the normal ups and downs of life?” 2) “After how many of your deliveries, within the first
six months postpartum, did you feel sad, miserable, or very anxious? By this we mean a
period of at least 2 weeks, when you were not yourself and which was worse than the
normal ups and downs of life?” For women answering yes to either question, we then asked
them to focus on the worst PND episode, and to complete the 10-item EPDS based on the
worst episode. We believed that asking about the worst episode would increase the accuracy
of reporting. We also included questions about the timing of initial onset of symptoms
(trimester of pregnancy or months postpartum), and history of seeking mental health
treatment for perinatal mood symptoms.
Risk factors and correlates
We examined the relation between PND and sociodemographic and other risk factors
including age marital status and history of a live birth at the 4-year follow-up assessment,
worst episode of lifetime PND, level of education, family history of MDD, personality
(degree of neuroticism), history of childhood and adult abuse/trauma, and presence of
lifetime anxiety disorder. We picked these risk factors based on the literature. Family history
of MDD among first degree relatives was obtained using the family tree method at the
baseline assessment (Fyer and Weissman 1999). Personality was evaluated using the NEO
personality questionnaire at the baseline assessment (Costa Jr and McCrae 1995). The
childhood trauma inventory, as assessed at baseline, quantified a cumulative childhood
trauma index consisting of emotional neglect, psychological abuse, physical abuse and
sexual abuse during the first 16 years of life (Wiersma 2009). Abuse that occurred after age
16 was assessed using an adverse life events scale(Brugha T 1985)._ Lifetime anxiety
disorder was based on CIDI interviews at baseline, 2-year, and 4-year follow-up(Penninx,
Beekman et al. 2008; Boschloo, Vogelzangs et al. 2011).
Statistical analyses
Analyses were conducted using SPSS (v.15. Chicago, Illinois). In our sample of women
with lifetime MDD who had a history of one or more live births, we explored the
performance of the lifetime EPDS using descriptive statistics and tested the internal
consistency using Cronbach’s alpha. As an indication for the validity of the EPDS, we tested
whether the clinical characteristics of non-PND (i.e., EPDS<12) and PND (i.e., EPDS≥12)
differed in a sample of women with lifetime MDD who answered yes on our two-item
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screener. Characteristics were summarized for women with PND and non-PND MDD and
these were compared to controls using χ2 statistics for categorical variables and analysis of
variance for continuous variables. To determine whether characteristics were specific risk-
indicators for PND or non-PND MDD, we tested differences in characteristics between
women with PND and non-PND MDD. Finally, we performed multivariate logistic
regression analyses to identify potential independent risk factors for PND.
RESULTS
Performance of the EPDS-Lifetime
We explored the performance of the EPDS-Lifetime in women with lifetime MDD who had
a live birth. Of all women with valid data on the screener (N=682), 363 women (53.3%)
screened positive on at least one of the two screening questions about lifetime mood and
anxiety symptoms during pregnancy (N=214) and/or after giving birth (N=266) (see also
Figure 1). We assessed EPDS scores among all women who screened positive on at least
one of the two screening questions and had valid data on the EPDS (n=361). EPDS scores
showed a normal distribution with a mean of 16.4 and standard deviation of 6.2. Cronbach’s
alpha for this scale was 0.82, indicating good internal consistency (Bland and Altman 1997).
Prevalence and Severity of PND and MDD in the NESDA Cohort
Of 361 women with MDD who endorsed one of the EPDS-Lifetime screening questions,
276 women (76.5%) had an EPDS score ≥12 indicating PND based on our study definition.
Table 2 shows that women with PND consistently demonstrated a more severe and chronic
clinical course of illness than women with MDD outside of the perinatal period, including
more functional impairment (p<0.001), having sought professional help (p<.001), and
receiving treatment (p=0.001).
When we examined women in NESDA with histories of MDD who gave birth to a living
child (N=682), 276 (40.6%) met criteria for PND in our study. Of those women with PND,
54.0% had experienced an episode of MDD before the onset of PND. Figure 2 depicts the
timing of the onset of symptoms in women with PND: 57.3% reported postpartum onset and
42.7% had onset during pregnancy. In the postpartum period, the largest percentage of
women reported onset of depression occurring within the first four weeks postpartum –
approximately 34%. An additional 13% reported on onset of symptoms between 4–12 weeks
postpartum and 10% reported onset after greater than 12 weeks (between 3–6 months
postpartum).
Risk Factors for PND and MDD
We compared risk characteristics for three groups: 1) women with a history of a live birth
and histories of MDD outside of the perinatal period (non-PND MDD); 2) women with a
history of a live birth and both MDD and PND (PND+MDD); and 3) a control group of
women with a history of a live birth who did not report a lifetime history of PND or MDD
(Table 3). The mean age at time of the NESDA 4-year follow-up interview of those with
PND+MDD was 47.9 years, significantly younger than the control and non-PND MDD
groups (p =0.002). In all groups, most were married or partnered and had a high school
education. A family history of MDD was significantly higher in the PND group compared to
those with non-PND MDD (p = 0.03) and controls (p <0.001). History of a lifetime anxiety
disorder was significantly higher in the PND group (p =.003) and the PND group had higher
neuroticism compared to the non-PND MDD group (p <0.001) and controls (p<.001).
Rates of abuse/trauma were high but particularly in women with PND. We observed
statistically significant increased rates of childhood trauma in the PND group compared to
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both the control (p <0.001) and the non-PND MDD groups (p =0.002). More than half
(54.7%) of women in the PND group reported childhood emotional neglect and this was
higher compared to the MDD only group (p =.003) and controls (p<0.001). Childhood
psychological abuse was increased in those with PND versus non-PND MDD only (p =0.02)
and controls (p <0.001). Moreover, 30.4% of those in the PND group reported a history of
childhood sexual abuse and 30.8% reported a history of sexual abuse after age of 16. This
finding was statistically significant compared to the non-PND MDD group only for those
with histories of sexual abuse after age 16 (p =0.001) but was highly significant compared to
controls at both time points (p <0.001).
Finally, multivariate logistic regression analyses were performed to identify independent
risk identifiers for PND compared to the non-PND MDD group. After adjustment for all
socio-demographic and vulnerability factors, younger age (p =0.009), greater education
(p=0.001), higher neuroticism (p=0.04), childhood trauma (total score) (p=0.03) and sexual
abuse after age 16 (p=0.04) emerged as significant independent risk factors for PND.
DISCUSSION
The NESDA cohort is the first study to use a newly modified version of the EPDS to assess
lifetime PND in a large, naturalistic cohort study. NESDA subjects were recruited from
three settings representing a broad range of individuals including those with histories of
MDD. Of women with histories of MDD who gave birth to a living child, 276 (40.6%) met
criteria for PND based on a positive lifetime EPDS score (EPDS≥12).
The EPDS-Lifetime performed well in our study. The internal consistency of the EPDS was
good (Cronbach’s α =0.82, with α > 0.7 defining acceptable internal consistency) (Bland
and Altman 1997). These results are encouraging and suggest that the EPDS-Lifetime could
be used in a variety of settings to screen women of reproductive age retrospectively for
lifetime PND. It would provide valuable information regarding women at risk of developing
a new episode of PND in a subsequent pregnancy and those who may be vulnerable to
reproductive mood disorders across the lifecycle (Schmidt, Nieman et al. 1998; Bloch,
Schmidt et al. 2000; Rubinow 2005; Rubinow and Schmidt 2006).
A strength of the present study is that it is one of the first to examine the prevalence of PND
in a large cohort of women with past histories of MDD diagnosed by structured clinical
interviews and to examine risk factors for PND. We found that 40% of parous women with
MDD had a history of PND. Women with PND reported the perinatal depressive episodes as
more severe than MDD episodes occurring outside of the perinatal period as evidenced by
being associated with greater impairments in daily functioning, more often seeking
professional help and initiating treatment. In terms of risk factors for PND, we found that a
family history of MDD, higher neuroticism, anxiety disorders and trauma significantly
increased risk. After controlling for all socio-demographic and vulnerability factors,
multivariate logistic regression identified significant independent risk factors for PND
including younger age, greater education, higher neuroticism, and history of childhood
trauma and sexual abuse after age 16. Taken together and consistent with the literature
(Silverman and Loudon 2010), this information supports the importance of screening and
monitoring women with histories of MDD throughout the perinatal period.
In our sample, 54% of women had already experienced an episode of MDD before the onset
of PND. This finding has significance for a number of important reasons. First, the timing of
onset of perinatal depression is an area of intense research and controversy within the field
of perinatal psychiatry(Elliott 2000; Gaynes, Gavin et al. 2005; Munk-Olsen, Laursen et al.
2006; Wisner, Moses-Kolko et al. 2010). The inherent heterogeneity of PND (phenotype by
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timing of onset of symptoms occurring before pregnancy, during pregnancy or postpartum)
has complicated efforts to determine underlying pathophysiology and to develop targeted
treatments. We examined the timing of onset of PND symptoms and found that 57.3% of
subjects reported an onset after delivery, whereas 42.7% had an onset during pregnancy. Of
women reporting onset of PND in the first trimester (～25%), we believe it possible that
most had an ongoing episode of MDD predating pregnancy.
Second, our findings support the clinical recommendation that women with histories of
MDD need to be monitored during the perinatal period as they are at risk for developing
PND. Most women have extensive contact with the health care system during pregnancy and
are open to screening and interventions that improve their health and that of their child
(Suellentrop K 2006; Dott, Rasmussen et al. 2010). Therefore, the perinatal period presents a
window of opportunity to actively screen for lifetime MDD, abuse and other important risk
factors in order to prevent adverse outcomes associated with PND.
The high prevalence of abuse in women with a history of PND is striking but consistent with
previous studies (Meltzer-Brody, Zerwas et al. ; Kendall-Tackett 2007; Onoye, Goebert et
al. 2009; Silverman and Loudon 2010). However, the sample size of the present study is
much larger than most prior work. More than half of the PND group reported histories of
neglect and almost one-third reported a history of sexual abuse. Furthermore, the long-term
psychological consequences of sexual abuse are well-documented and associated with
adverse consequences on emotional and physical health (Leserman, Drossman et al. 1996;
McCauley, Kern et al. 1997; Kendler, Bulik et al. 2000; Romans, Belaise et al. 2002;
Leserman 2005) and increased risk for adverse outcomes during the perinatal period (Buist
1998; Grimstad, Backe et al. 1998; Leeners, Richter-Appelt et al. 2006; Leeners, Stiller et al.
2010; Lukasse, Vangen et al. 2011).
The methodological strengths of this study include the analysis of a notably large sample of
women with a history of MDD diagnosed by administration of a structured psychiatric
interview and compared to a new lifetime assessment of PND. The primary limitations of
our study are the retrospective nature of the assessment of lifetime PND and lack of data on
some other aspects of pre-partum functioning. In addition, in the PND+MDD group,
compared to the PND alone group, the increased psychiatric comorbidity and severity of
illness could be due in part to the greater number of lifetime episodes of unipolar major
depression. As women with bipolar disorder were excluded from the NESDA study, we
were not able to examine the prevalence or severity of PND in those with bipolar disorder
and compare to those with unipolar MDD.
CONCLUSIONS
PND is a severe and persistent form of MDD that is one of the most frequent complications
of pregnancy and childbirth. NESDA is one of the first studies to carefully assess for
lifetime history of PND in a large sample of women with MDD. In this sample, a new
modified, lifetime version of the EPDS (the EPDS-Lifetime), demonstrated great promise as
a useful tool for the assessment of lifetime histories of PND. Two in five women with a live
birth and a history of MDD also had lifetime PND, and the PND episodes were more severe
than MDD occurring outside of the perinatal period. Histories of abuse and trauma were
significantly increased in women with PND, compared to women with non-perinatal MDD
as well as healthy controls. Identification of the independent risk factors and phenotypic
characteristics that distinguish PND from MDD has important and far reaching clinical and
research implications that could provide insight into psychological, biological and genetic
vulnerabilities to PND. Specifically, the perinatal period presents a window of opportunity
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to actively screen for lifetime histories of depression, abuse and other important risk factors
of psychiatric illness.
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Table 1
Modified Lifetime Version of the Edinburgh Postnatal Depression Scale
How many times have you been pregnant? _____
If you have NEVER been pregnant, SKIP to SECTION XXX BELOW.
How many of these pregnancies resulted in live births (including caesarean sections)? _____
If NONE of your pregnancies resulted in a live birth, AND SKIP to SECTION XXX BELOW
During how many of your pregnancies did you feel sad, miserable, or very anxious? By this we
mean a period of at least 2 weeks when you were not yourself and which was worse than the normal
ups and downs of life? _____
After how many of your deliveries, within the first six months postpartum, did you feel sad,
miserable, or very anxious? By this we mean a period of at least 2 weeks, when you were not
yourself and which was worse than the normal ups and downs of life? _____
Please think about the worst episode during pregnancy or after delivery.
During the worst episode of feeling sad, miserable, or very anxious during pregnancy or following
delivery, how often:
Often Sometimes Rarely Never
• Did you feel able to laugh or see the funny side of things? ___ ___ ___ ___
• Were you able to look forward to things with excitement? ___ ___ ___ ___
• Did you blame yourself unnecessarily when things went wrong? ___ ___ ___ ___
• Were you anxious or worried for no good reason? ___ ___ ___ ___
• Did you feel scared or panicky for no good reason? ___ ___ ___ ___
• Did you feel overwhelmed? ___ ___ ___ ___
• Were you so unhappy that you had difficulty sleeping? ___ ___ ___ ___
• Did you feel sad or miserable? ___ ___ ___ ___
• Were you so unhappy that you cried? ___ ___ ___ ___
• Did the thought of harming yourself occur to you? ___ ___ ___ ___
Severity and Timing of Onset: During the worst episode of feeling sad, miserable, or very anxious
during pregnancy or following delivery:
Yes No
a. Were the symptoms so severe that you sought professional help? ___ ___
b. Did the symptoms cause you problems or interfere with your day-to-day life? ___ ___
c. Did you require psychiatric hospitalization because of these symptoms? ___ ___
d. Did you receive any form of treatment such as counseling or medication because of depression
during pregnancy or following delivery?__
No Treatment __Counseling __Medication __Counseling and Medication
e. During the worst episode, when did these symptoms begin? During Pregnancy: __1st trimester
__2nd trimester __3rd trimester After Delivery: __0–4 weeks __1–3 months __more than 3
months postpartum
f. During the worst episode, how long did these symptoms last? ___ Up to 2 weeks ___2–4 weeks
___1–3 months ___3–6 months ___ more than 6 months
g. How old were you during the worst episode? _____
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Table 2





Characteristic n (%) n (%) p
Impairments in day-to-day life (yes) 39 (45.9%) 236 (85.5%) <0.001
Duration of symptoms: <0.001
  − 0–2 weeks 16 (18.8%) 2 (0.7%)
  − 2–4 weeks 16 (18.8%) 27 (9.8%)
  − 1–3 months 22 (25.9%) 65 (23.6%)
  − 3–6 months 15 (17.6%) 68 (24.6%)
  − >6 months 16 (18.8%) 114 (41.3%)
Sought professional help (yes) 23 (27.1%) 138 (50.0%) <0.001
Received treatment (counseling/medication; yes) 15 (17.6%) 101 (36.6%) 0.001
a
In a sample of women with lifetime MDD who had experienced feelings of sadness or anxiety during pregnancy or after delivery of a living child
and had complete data on the EPDS (n=361).
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